Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D06YEB
|
||||
Former ID |
DNC007786
|
||||
Drug Name |
1-(10H-phenothiazin-10-yl)-3-phenylbutan-1-one
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [1] | ||
Structure |
![]() |
Download2D MOL |
|||
Formula |
C22H19NOS
|
||||
Canonical SMILES |
CC(CC(=O)N1C2=CC=CC=C2SC3=CC=CC=C31)C4=CC=CC=C4
|
||||
InChI |
1S/C22H19NOS/c1-16(17-9-3-2-4-10-17)15-22(24)23-18-11-5-7-13-20(18)25-21-14-8-6-12-19(21)23/h2-14,16H,15H2,1H3
|
||||
InChIKey |
WFXGFQNNLYOETN-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Cholinesterase | Target Info | Inhibitor | [1] | |
PANTHER Pathway | Muscarinic acetylcholine receptor 1 and 3 signaling pathway | ||||
Muscarinic acetylcholine receptor 2 and 4 signaling pathway | |||||
Nicotinic acetylcholine receptor signaling pathway | |||||
WikiPathways | Irinotecan Pathway | ||||
References | |||||
REF 1 | Bioorg Med Chem. 2007 Oct 1;15(19):6367-78. Epub 2007 Jul 6.Selective reversible inhibition of human butyrylcholinesterase by aryl amide derivatives of phenothiazine. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.